Healthcare -
Biotechnology - NASDAQ - US
$ 54.4243
4.44 %
$ 3.37 B
Market Cap
69.0
P/E
PTGX - NET INCOME
Net Income PTGX - Protagonist Therapeutics, Inc.
275 M
LAST VALUE
103.96%
2 YEAR CAGR
40.96%
5 YEAR CAGR
38.96%
10 YEAR CAGR